Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy

Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy

Chenwei Pan,1,* Tiaotiao Zhang,2,3,* Shaoxun Li,1,3,* Zhihua Xu,2,3 Binhui Pan,2,3 Sheng Xu,2,3 Shuanghong Jin,1,3 Guangrong Lu,2 Shouxing Yang,2 Zhanxiong Xue,2 Ping Chen,4 Xian Shen,5 Fangyan Wang,6 Changlong Xu2,7 1Department of Infectious Disease, Second Affiliated Hospital and Yuying Children&a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pan C, Zhang T, Li S, Xu Z, Pan B, Xu S, Jin S, Lu G, Yang S, Xue Z, Chen P, Shen X, Wang F, Xu C
Format: article
Langue:EN
Publié: Dove Medical Press 2021
Sujets:
cationic hybrid nanoparticles
hyaluronic acid (ha)
hsp90 inhibitor
colon cancer
targeted delivery system
Medicine (General)
R5-920
Accès en ligne:https://doaj.org/article/59eef45e92c945498fd61626b92a6e41
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/59eef45e92c945498fd61626b92a6e41

Documents similaires